Roles for fibroblast growth factor-23 and α-Klotho in acute kidney injury

Metabolism. 2021 Mar:116:154435. doi: 10.1016/j.metabol.2020.154435. Epub 2020 Nov 19.

Abstract

Acute kidney injury is a global disease with high morbidity and mortality. Recent studies have revealed that the fibroblast growth factor-23-α-Klotho axis is closely related to chronic kidney disease, and has multiple biological functions beyond bone-mineral metabolism. However, although dysregulation of fibroblast growth factor-23-α-Klotho has been observed in acute kidney injury, the role of fibroblast growth factor-23-α-Klotho in the pathophysiology of acute kidney injury remains largely unknown. In this review, we describe recent findings regarding fibroblast growth factor-23-α-Klotho, which is mainly involved in inflammation, oxidative stress, and hemodynamic disorders. Further, based on these recent results, we put forth novel insights regarding the relationship between the fibroblast growth factor-23-α-Klotho axis and acute kidney injury, which may provide new therapeutic targets for treating acute kidney injury.

Keywords: Acute kidney injury; Fibroblast growth factor-23; α-Klotho.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Acute Kidney Injury / etiology
  • Acute Kidney Injury / genetics*
  • Acute Kidney Injury / pathology
  • Acute Kidney Injury / therapy
  • Animals
  • Fibroblast Growth Factor-23
  • Fibroblast Growth Factors / physiology*
  • Glucuronidase / physiology*
  • Humans
  • Klotho Proteins
  • Molecular Targeted Therapy / methods
  • Molecular Targeted Therapy / trends
  • Signal Transduction / physiology

Substances

  • Fibroblast Growth Factors
  • Fibroblast Growth Factor-23
  • Glucuronidase
  • Klotho Proteins